Physician profile
Jason Moore
NPI 1023037348
$4,187.84
in general payments reported to CMS, 2019-2025
14 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $401 · 2021: $665 · 2022: $636 · 2023: $499 · 2024: $1,026 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Travel and Lodging: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.14 |
| Travel and Lodging | $302.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,002.28 | 2021-2024 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| W. L. Gore & Associates, INC. | $608.64 | 2019-2022 | |
| Silk Road Medical, INC. | $483.88 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbott Laboratories | $310.36 | 2019-2020 | |
| Medtronic Vascular, INC. | $207.72 | 2019-2020 | |
| Boston Scientific Corporation | $147.43 | 2025 | Enroute Transcarotid Neuroprotection System |
| Shockwave Medical, INC | $108.23 | 2020-2021 | |
| Kerecis Limited | $104.04 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Penumbra, INC. | $100.91 | 2020 | |
| Smith+Nephew, INC. | $47.95 | 2022 | |
| Misonix INC | $26.01 | 2020-2021 | |
| Biocompatibles, INC. | $18.72 | 2019 | |
| Inari Medical, INC. | $17.63 | 2022 | |
| Reflow Medical INC | $4.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.